Trial · NCT00844649
Adverse events584
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 584
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Fatigue | General disorders | Albumin-bound Paclitaxel (ABI-007)/Gemcitabine | 247 | 421 | |
| other | Fatigue | General disorders | Gemcitabine | 183 | 402 | |
| other | Oedema peripheral | General disorders | Albumin-bound Paclitaxel (ABI-007)/Gemcitabine | 194 | 421 | |
| other | Oedema peripheral | General disorders | Gemcitabine | 123 | 402 | |
| other | Pyrexia | General disorders | Albumin-bound Paclitaxel (ABI-007)/Gemcitabine | 160 | 421 | |
| other | Pyrexia | General disorders | Gemcitabine | 111 | 402 | |
| other | Asthenia | General disorders | Albumin-bound Paclitaxel (ABI-007)/Gemcitabine | 77 | 421 | |
| other | Asthenia | General disorders | Gemcitabine | 51 | 402 | |
| other | Chills | General disorders | Albumin-bound Paclitaxel (ABI-007)/Gemcitabine | 48 | 421 | |
| other | Chills | General disorders | Gemcitabine | 34 | 402 | |
| other | Mucosal inflammation | General disorders | Albumin-bound Paclitaxel (ABI-007)/Gemcitabine | 42 | 421 | |
| other | Mucosal inflammation | General disorders | Gemcitabine | 16 | 402 | |
| other | Pain | General disorders | Albumin-bound Paclitaxel (ABI-007)/Gemcitabine | 24 | 421 | |
| other | Pain | General disorders | Gemcitabine | 8 | 402 | |
| other | Nausea | Gastrointestinal disorders | Albumin-bound Paclitaxel (ABI-007)/Gemcitabine | 223 | 421 | |
| other | Nausea | Gastrointestinal disorders | Gemcitabine | 189 | 402 | |
| other | Diarrhoea | Gastrointestinal disorders | Albumin-bound Paclitaxel (ABI-007)/Gemcitabine | 182 | 421 | |
| other | Diarrhoea | Gastrointestinal disorders | Gemcitabine | 94 | 402 | |
| other | Vomiting | Gastrointestinal disorders | Albumin-bound Paclitaxel (ABI-007)/Gemcitabine | 145 | 421 | |
| other | Vomiting | Gastrointestinal disorders | Gemcitabine | 107 | 402 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00844649/events